Leadership

ContraVir leadership brings deep experience in the development and commercialization of targeted antiviral therapies for indications of important unmet need.

James Sapirstein, R.Ph., M.B.A.

Chief Executive Officer

John Cavan

Chief Financial Officer

John Sullivan-Bolyai, M.D., MPH

Chief Medical Officer

Robert Foster, Pharm.D., Ph.D.

Chief Scientific Officer

Theresa Matkovits, Ph.D.

Executive VP, Head of Drug Development

Gary S. Jacob, Ph.D.

Chairman of the Board

John P. Brancaccio, C.P.A.

Board of Directors

Timothy M. Block, Ph.D.

Board of Directors

Arnold Lippa, Ph.D.

Board of Directors

Tamar D. Howson

Board of Directors

Thomas H. Adams, Ph.D.

Board of Directors

Carol Brosgart, M.D.

Scientific Advisory Board

Jordan Feld, M.D., M.P.H

Scientific Advisory Board

Philippe Gallay, Ph.D.

Scientific Advisory Board

Jörg Petersen, M.D, Ph.D.

Scientific Advisory Board

Fabien Zoulim, M.D., Ph.D.

Scientific Advisory Board

Nikolai V. Naoumov, M.D., Ph.D.

Scientific Advisory Board

Nathaniel Katz, M.D.

Scientific Advisory Board